Program Details

General Details

Tuesday, November 17, 2020

Program/Q&A  6:00 – 7:15PM
Exhibit Hall  7:15– 7:30PM

 

Location

Virtual Program. Link will be sent to registered attendees.

Laura W. Goff, MD, MSCI
Executive Director for the Cancer Patient Care Center
Vanderbilt-Ingram Cancer Center
Associate Professor of Medicine
Medical Director, Hematology-Oncology
Vanderbilt University Medical Center

Topic: Advances in systemic therapy for liver disease

Objectives:
1. Review new treatments for advanced hepatocellular carcinoma.
2. Discuss the role of molecular testing in cholangiocarcinomoa to guide therapy.

 

Andrew Scanga, MD
Assistant Professor
Medical Director of Hepatology Clinic  
VUMC

Topic: Update on HCC

Objectives:
1. Review the basic epidemiology
2. Review surveillance/diagnostic modalities
3. Review surgical and local/regional therapies for HCC

The University of New England College of Osteopathic Medicine (UNE COM) is accredited by the American Osteopathic Association (AOA) and the Maine Medical Association‘s Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians..
The AOA Council on Continuing Medical Education approved this CME Activity for a maximum of 1.25 hours of AOA Category  2-A CME credits. UNE COM designates this CME activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™ and 1.25 University of New England contact hours for non-physicians.  Contact hours may be submitted by non-physician, non-PA health professionals for continuing education credits.
This activity has been planned and implemented in accordance with the accreditation requirements & policies of the Maine Medical Association through the joint providership of University of New England College of Osteopathic Medicine (UNE COM) and the American Liver Foundation Mid-South Division.  University of New England is accredited by the Maine Medical Association to provide continuing medical education for physicians.